The decision, which will affect Aetna’s commercially insured members, aims to improve access to COVID-19 treatment by eliminating out-of-pocket expenses for patients. The move builds on measures taken by Aetna to waive cost-sharing for COVID-19-related telemedicine and testing.
The policy, effective immediately for any admission through June 1, only applies to inpatient admissions at in-network facilities. It covers treatment for COVID-19 or health complications associated with the disease.
In addition, Aetna is lifting prior approval requirements in hard-hit states like New York and Washington for COVID-19 hospitalizations. The insurer is also working with hospitals to expedite transfers of patients who don’t have COVID-19 to other appropriate care settings.
More articles on payers:
UnitedHealth updates remote work policy
COVID-19: 6 updates for health insurers
COVID-19: 6 latest updates from insurers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
